These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15375577)

  • 1. CD82, and CD63 in thyroid cancer.
    Chen Z; Mustafa T; Trojanowicz B; Brauckhoff M; Gimm O; Schmutzler C; Köhrle J; Holzhausen HJ; Kehlen A; Klonisch T; Finke R; Dralle H; Hoang-Vu C
    Int J Mol Med; 2004 Oct; 14(4):517-27. PubMed ID: 15375577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.
    Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M
    Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma.
    Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ
    Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer.
    Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ; Lu CH; Chiou LC
    Clin Cancer Res; 2003 Apr; 9(4):1393-8. PubMed ID: 12684410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of KAI1 expression in the progression of colorectal cancer.
    Lombardi DP; Geradts J; Foley JF; Chiao C; Lamb PW; Barrett JC
    Cancer Res; 1999 Nov; 59(22):5724-31. PubMed ID: 10582691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
    Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M
    Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KAI1/CD82 expression as a prognosic factor in sporadic colorectal cancer.
    Muneyuki T; Watanabe M; Yamanaka M; Shiraishi T; Isaji S
    Anticancer Res; 2001; 21(5):3581-7. PubMed ID: 11848527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of tumor metastasis suppressor gene KAI1 in digestive tract carcinomas and cancer cells.
    Wu Q; Ji Y; Zhang MQ; Chen YQ; Chen F; Shi DL; Zheng ZH; Huang YJ; Su WJ
    Cell Tissue Res; 2003 Nov; 314(2):237-49. PubMed ID: 12955496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KAI1/CD82 gene expression in benign prostatic hyperplasia and late-stage prostate cancer in Chinese.
    Hu WL; Li YQ; He HX; Li QR; Tian Y; Lai RQ; Mei H
    Asian J Androl; 2000 Sep; 2(3):221-4. PubMed ID: 11225981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of tetraspanin adaptor proteins below defined threshold values is associated with in vitro invasiveness of mammary carcinoma cells.
    Sauer G; Kurzeder C; Grundmann R; Kreienberg R; Zeillinger R; Deissler H
    Oncol Rep; 2003; 10(2):405-10. PubMed ID: 12579280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma.
    Guo XZ; Friess H; Di Mola FF; Heinicke JM; Abou-Shady M; Graber HU; Baer HU; Zimmermann A; Korc M; Büchler MW
    Hepatology; 1998 Dec; 28(6):1481-8. PubMed ID: 9828210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of telomerase genes in thyroid carcinoma.
    Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
    Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KAI1 protein is down-regulated during the progression of human breast cancer.
    Yang X; Wei L; Tang C; Slack R; Montgomery E; Lippman M
    Clin Cancer Res; 2000 Sep; 6(9):3424-9. PubMed ID: 10999724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and clinical significance of p53, JunB and KAI1/CD82 in human hepatocellular carcinoma.
    Guo C; Liu QG; Zhang L; Song T; Yang X
    Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):389-96. PubMed ID: 19666408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer.
    Sho M; Adachi M; Taki T; Hashida H; Konishi T; Huang CL; Ikeda N; Nakajima Y; Kanehiro H; Hisanaga M; Nakano H; Miyake M
    Int J Cancer; 1998 Oct; 79(5):509-16. PubMed ID: 9761121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases.
    Guo X; Friess H; Graber HU; Kashiwagi M; Zimmermann A; Korc M; Büchler MW
    Cancer Res; 1996 Nov; 56(21):4876-80. PubMed ID: 8895737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of CD151 gene expression in non-small cell lung cancer.
    Tokuhara T; Hasegawa H; Hattori N; Ishida H; Taki T; Tachibana S; Sasaki S; Miyake M
    Clin Cancer Res; 2001 Dec; 7(12):4109-14. PubMed ID: 11751509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of TM4SF is associated with the metastatic potential of gastric carcinoma TM4SF members in gastric carcinoma.
    Chen Z; Gu S; Trojanowicz B; Liu N; Zhu G; Dralle H; Hoang-Vu C
    World J Surg Oncol; 2011 Apr; 9():43. PubMed ID: 21521534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.
    Uzawa K; Ono K; Suzuki H; Tanaka C; Yakushiji T; Yamamoto N; Yokoe H; Tanzawa H
    Clin Cancer Res; 2002 Mar; 8(3):828-35. PubMed ID: 11895916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.
    Zhou B; Liu L; Reddivari M; Zhang XA
    Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.